Genotyping of the capsule gene cluster (cps) in nontypeable group B Streptococci reveals two major cps allelic variants of serotypes III and VII

Journal of Clinical Microbiology

Volumn 38, Issue 9, 2000, Pages 3420-3428

  Sellin, M ^a   Olofsson, C ^a   Hakansson, S ^a   Norgren, M ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTERIUM IDENTIFICATION; CLINICAL ARTICLE; DENSITY GRADIENT CENTRIFUGATION; GENE CLUSTER; GENE ISOLATION; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; NEWBORN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEROTYPING; STREPTOCOCCUS AGALACTIAE;

ANIMALIA; BACTERIA (MICROORGANISMS); POSIBACTERIA; STREPTOCOCCUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS SP. 'GROUP B';

EID: 0033823862     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.9.3420-3428.2000     Document Type: Article

References (39)

1. Inhibition enzyme-linked immunosorbent assay for serotyping of group B streptococcal isolates
2. Laboratory procedures for the epidemiologic analysis of microorganisms
3. Group B streptococcal infections
4. Invasive group B streptococcal disease: The emergence of serotype V
5. Anorectal and vaginal carriage of group B streptococci during pregnancy
6. A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults
7. Molecular analysis of multiple isolates of the major serotypes of group B streptococci
8. Identification of a novel insertion element, IS1548, in group B streptococci, predominantly in strains causing endocarditis
9. Demonstration and characterization of buoyant density subpopulations of group B Streptococcus type III
10. Novel coagglutination method for serotyping group B streptococci
11. Serotype distribution of invasive group B streptococcal isolates in Maryland: Implications for vaccine formulation. Maryland Emerging Infections Program
12. Population structure of Streptococcus agalactiae reveals an association between specific evolutionary lineages and putative virulence factors but not disease
13. Clonal analysis of Streptococcus agalactiae isolated from infants with neonatal sepsis or meningitis and their mothers and from healthy pregnant women
14. Changing epidemiology of group B streptococcal colonization
15. Risk factors for group B streptococcal disease in adults
16. Capsular polysaccharides as vaccine candidates
17. Production and evaluation of antisera for serological type determination of group-B streptococci by double diffusion in agarose gel
18. Structural and immunochemical characterization of the type VIII group B Streptococcus capsular polysaccharide
19. Structural elucidation of the novel type VII group B Streptococcus capsular polysaccharide by high resolution NMR spectroscopy
20. Identification of two genes, cpsX and cpsY, with putative regulatory function on capsule expression in group B streptococci
21. Distribution of serovariants of group B streptococci in isolates from England and Norway
22. Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women
23. A serological differentiation of human and other groups of hemolytic streptococci
24. Capsular polysaccharide types of group B streptococcal isolates from neonates with early-onset systemic infection
25. Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease
26. Agglutination and agglutination inhibition assays
27. Decreased capacity for type-specific-antigen synthesis accounts for high prevalence of nontypeable strains of group B streptococci in Mexico
28. Nosocomial streptococcal blood stream infections in the SCOPE program: Species occurrence and antimicrobial resistance
29. Genetic features of Streptococcus agalactiae strains causing severe neonatal infections, as revealed by pulsed-field gel electrophoresis and hylB gene analysis
30. IS861, a group B streptococcal insertion sequence related to IS150 and IS3 of Escherichia coli
31. Identification of cpsD, a gene essential for type III capsule expression in group B streptococci
32. Phase-shift of polysaccharide capsule expression in group B streptococci, type III
33. Endocarditis caused by a group B Streptococcus strain, type III, in a nonencapsulated phase
34. Stable thiobarbituric acid chromophore with dimethyl sulphoxide. Application to sialic acid assay in analytical de-O-acetylation
35. Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci)
36. Definition of a bacterial virulence factor: Sialylation of the group B streptococcal capsule
37. Structural determination and immunochemical characterization of the type V group B Streptococcus capsular polysaccharide
38. Isolation and characterization of type IV group B Streptococcus capsular polysaccharide
39. Molecular characterization of type-specific capsular polysaccharide biosynthesis genes of Streptococcus agalactiae type Ia